All news

Member Update from Turkey
16 February 2023

The devastating earthquakes that struck southern Türkiye and northern Syria on 6 February have destroyed homes, hospitals, and roads.

...

Read

How Is Your Country Doing? Launch of European Country Cancer Profiles
16 February 2023

Together with nearly 200 participants, DiCE joined the online launch of Country Cancer Profiles on the European Cancer Inequalities Registry. The ...

Read

European Commission Gathered Evidence on Vaccine-preventable Cancers
16 February 2023

Earlier this month, DiCE responded to the call for evidence by the EU Commission. DiCE highlighted that to mitigate the rising incidence of Liver ...

Read

DiCE Supports Act4Biosimilars to Increase Patient Access to Biologic Medicines
16 February 2023

On 30 January, the Act4Biosimilars initiative hosted a virtual meeting with key stakeholders from across the healthcare space to discuss the Action...

Read

16 February is World Cholangiocarcinoma Day
13 February 2023

DiCE is proud to support GCCA’s international effort to raise much-needed awareness of CCA, devastating cancer that occurs in the bile ducts in o...

Read

Interventions to Reduce Cancer Screening Inequities
1 February 2023

A group of patients and patient advocacy organisations published a promising multistep strategy to reduce cancer screening inequalities In Internat...

Read

First Immunotherapy Drug Durvalumab Plus Chemotherapy Approved in Europe for Advanced Biliary Cancer
11 January 2023

On 21 December the European Commission (EC) approved the use of durvalumab (Imfinzi ®) plus chemotherapy (gemcitabine plus cisplatin) as the first...

Read

The EC Approves Nivolumab Plus Chemotherapy as First Line Treatment for Oesophageal Cancer
Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer
11 January 2023

On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin...

Read

Nutrition Position Paper
12 December 2022

Nutritional intervention is essential to cancer treatments. It can reduce hospitalisation length and treatment-related toxicity while improving nut...

Read

Member Organisation Update
4 December 2022

News From The North, PALEMA’s Tireless Efforts During The Months of October and November

...

Read

Stay updated about digestive cancer news

Subscribe to our newsletter for updates about our organization, news about our members or medical news about digestive cancers.

Press

For all press inquiries, please drop us a mail.

To the press section

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.